We stand for our clients.
Call us today: (866) 468-8631

Firm Donates $250,000 to Mesothelioma Applied Research Foundation

The Foundation’s Largest Cumlative Donor Focuses on Helping Families Affected by Mesothelioma

EAST ALTON, Ill., March 1, 2011 – The Simmons Hanly Conroy today announced a donation of $250,000 to the Mesothelioma Applied Research Foundation to become a “2011 Legal Partner for a Cure” diamond sponsor. The foundation is the national non-profit dedicated to eradicating mesothelioma as a life-ending disease by funding research, providing education and support for patients, and leading advocacy efforts for a national commitment to end the mesothelioma tragedy.  In addition, Simmons Hanly Conroy will help support the foundation’s Annual International Symposium on Malignant Mesothelioma to be held June 23-25, 2011, in Washington, D.C.

MARF-Dia-11-web

“As a law firm who has represented thousands of families affected by mesothelioma, we truly appreciate the hope and awareness the Mesothelioma Applied Research Foundation provides,” said Simmons Hanly Conroy Managing Partner Mike Angelides. “Our firm is honored to once again make this contribution in support of work that means so much to our own clients and to all mesothelioma patients and their families affected by the disease.”

To date, the foundation has funded over $7.1 million in peer-reviewed mesothelioma research. The Simmons Hanly Conroy is the foundation’s top cumulative donor with more than $2 million contributed to its programs.

MesoFoundation_Seal_of_Partnership_2011-web

“Funding peer-reviewed research and offering authoritative medical expertise to all mesothelioma patients and their families are the core purposes of the foundation,” said Meso Foundation Executive Director Kathleen Wiedemer. “Through the Simmons law firm’s leadership level of support in our 2011 Legal Partners Program, the foundation will be well-positioned to continue our efforts to help the mesothelioma community, promote awareness of this devastating disease and continue supporting medical researchers as they work toward a cure.”



91 queries. 0.410 seconds